7Baggers
 Brokerages Set TScan Therapeutics, Inc. (NASDAQ:TCRX) PT at $7.80  MarketBeat Mon, 22 Sep 2025 07:18:15 GMT
 TScan Therapeutics Announces Upcoming Oral and Poster  GlobeNewswire Wed, 17 Sep 2025 07:00:00 GMT
 published on: 2025-09-16 04:40:28  خودرو بانک Tue, 16 Sep 2025 01:10:33 GMT
 tscan therapeutics updates corporate milestones and strategies  The Globe and Mail Wed, 10 Sep 2025 11:42:00 GMT
 TScan Therapeutics Updates Corporate Milestones and Strategies  TipRanks Tue, 09 Sep 2025 07:00:00 GMT
 published on: 2025-09-08 14:23:38  Newser Mon, 08 Sep 2025 19:23:38 GMT
 hsbc holdings plc invests $49,000 in tscan therapeutics, inc. $tcrx  Defense World Mon, 08 Sep 2025 08:05:30 GMT
 bvf inc. il raises holdings in tscan therapeutics, inc. $tcrx  MarketBeat Mon, 08 Sep 2025 07:00:00 GMT
 TScan Therapeutics to Participate in Upcoming Investor Conferences  GlobeNewswire Wed, 03 Sep 2025 07:00:00 GMT
 published on: 2025-09-03 01:05:15  Newser Wed, 03 Sep 2025 06:05:15 GMT
 can tscan therapeutics inc. deliver alpha - bond market & weekly momentum picks  خودرو بانک Wed, 03 Sep 2025 00:21:37 GMT
 deutsche bank ag increases position in tscan therapeutics, inc. $tcrx  Defense World Tue, 02 Sep 2025 07:26:35 GMT

Tscan Therapeutics Inc
(NASDAQ:TCRX) 

TCRX stock logo

TScan Therapeutics is a biopharmaceutical company focused on the development of immunotherapy treatments for cancer.

Founded: 2018
CEO: David Southwell  
Sector:
Industry:

Share this website to your friends